Global Non-Invasive Prenatal Testing (NIPT) Market by P&S Market Research
Based on test type, the MaterniT21 PLUS segment led the global NIPT market in 2014 with the largest market size. It was the first test introduced in the market for the diagnosis of Trisomy 21, in 2011. However, the NIFTY test segment is expected to grow with the fastest rate, among the various test type segments during the forecast period.
Based on test type, the MaterniT21 PLUS segment led the global NIPT market in 2014 with the largest market size. It was the first test introduced in the market for the diagnosis of Trisomy 21, in 2011. However, the NIFTY test segment is expected to grow with the fastest rate, among the various test type segments during the forecast period.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Non</strong>-<strong>Invasive</strong> <strong>Prenatal</strong> <strong>Testing</strong> (<strong>NIPT</strong>) <strong>Market</strong> is Expected to Grow at<br />
17.6% CAGR During 2015 – 2020<br />
The global non-invasive prenatal testing (<strong>NIPT</strong>) market was valued at $563.4 million in 2014, and it is expected to<br />
grow with a CAGR of 17.6% during the period 2015 - 2020. The global <strong>NIPT</strong> market is growing, due to increasing<br />
healthcare expenditure. The average maternal age is increasing in high income countries, due to changing<br />
pattern of employment, education and marriage, and increasing cost of raising a child. The increase in average<br />
maternal age is resulting in the growth of the global <strong>NIPT</strong> market. Chromosome syndromes are caused, due to<br />
chromosomal abnormalities in the humans, which is leading to genetic cause of miscarriage and congenital birth<br />
defects. According to the World Health Organization (WHO), each year approximately 3,000 to 5,000 children are<br />
born with chromosome disorder. Thus, with the increase in chromosome syndrome cases, the need for early and<br />
advance prenatal screening is increasing, which is resulting in increased demand for <strong>NIPT</strong>.<br />
Explore Report Description with Detailed TOC on “<strong>Global</strong> <strong>NIPT</strong> <strong>Market</strong>” at:<br />
https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market<br />
Based on test type, the MaterniT21 PLUS segment led the global <strong>NIPT</strong> market in 2014 with the largest market<br />
size. It was the first test introduced in the market for the diagnosis of Trisomy 21, in 2011. However, the NIFTY<br />
test segment is expected to grow with the fastest rate, among the various test type segments during the forecast<br />
period.<br />
TABLE OF CONTENT<br />
Chapter 1. <strong>Research</strong> Scope and Methodology<br />
1.1 <strong>Market</strong> Definition<br />
1.2 <strong>Market</strong> Scope<br />
1.2.1 <strong>Global</strong> <strong>NIPT</strong> market breakdown <strong>by</strong> test type<br />
1.2.2 <strong>Global</strong> <strong>NIPT</strong> market breakdown <strong>by</strong> geography<br />
1.3 <strong>Research</strong> Methodology and Sources<br />
Chapter 2. Executive Summary<br />
2.1 Key Findings<br />
2.2 <strong>Research</strong> Summary<br />
Chapter 3. <strong>Market</strong> Outlook<br />
© P&S <strong>Market</strong> <strong>Research</strong>. All rights reserved 2
Change language